Shockwave Medical, Inc. (NASDAQ: SWAV) (“Shockwave”), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, has announced the completion of its previously announced acquisition of Neovasc Inc. (“Neovasc”). Neovasc is a specialty medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular marketplace. Its products include Reducer, for the treatment of refractory angina, which is under clinical investigation in the United States and has been commercially available in Europe since 2015.
Read the full article: Shockwave Medical Completes Acquisition of Neovasc //
Source: https://www.globenewswire.com/news-release/2023/04/11/2644379/0/en/Shockwave-Medical-Completes-Acquisition-of-Neovasc.html